Stemness-associated transcriptional profiles reveal prognostic and microenvironmental heterogeneity in osteosarcoma

Background Osteosarcoma (OS) is an aggressive primary bone malignancy with poor outcomes in patients with recurrent or metastatic disease. Although molecular profiling has revealed substantial heterogeneity in OS, the relationships between stemness-associated gene expression, patient prognosis, and the tumor immune microenvironment remain incompletely understood. Methods In this study, non-negative matrix factorization of stemness-associated gene expression was used to identify molecular subtypes in TARGET-OS. Functional enrichment, weighted gene co-expression network analysis, somatic mutation profiling, and drug response prediction characterized subtype differences. After joint batch correction of TARGET-OS and GSE21257, an overall survival model based on stemness-associated gene expression was developed using LASSO and Cox regression in TARGET-OS and evaluated in GSE21257. Immune infiltration and single-cell transcriptomic analyses characterized the associated immune features, cellular distribution of the signature, and potential cell–cell interactions. Results Our analysis identified two exploratory stemness-associated OS subtypes with distinct prognoses in the TARGET-OS cohort. C1 showed poorer survival and enrichment of metabolic and DNA repair programs, whereas C2 was enriched for extracellular matrix and immune-related processes. Drug response predictions indicated greater sensitivity to fixed-ratio combinations containing selumetinib in C1 and to cabozantinib in C2. We developed a nine-gene signature that stratified overall survival in both cohorts, with 1-, 3-, and 5-year AUCs of 0.653, 0.751, and 0.711, respectively, in GSE21257. High-risk tumors exhibited lower immune scores and reduced estimated infiltration of CD8 + T Cells and B Cells. Single-cell analysis revealed relatively high signature scores in OS cells and cancer-associated fibroblasts. The high-scoring OS1 subpopulation was enriched for ossification and extracellular matrix-related processes. Communication analysis further predicted COL1A1–CD44 interactions from OS cells and fibroblasts to monocytes. Conclusion Our study characterizes stemness-associated transcriptional heterogeneity in OS and identifies a nine-gene prognostic signature. These findings associate survival differences with metabolic and immune programs and reveal the cellular expression patterns of the signature in tumor and stromal cells.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2026-11-18
DOI
https://doi.org/10.3389/fgene.2026.2027108
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Stemness-associated transcriptional profiles reveal prognostic and microenvironmental heterogeneity in osteosarcoma

Gaohui Fu, Fei Yu, Qiang Lian, Xiaojia Liu et al.
2 links
Frontiers in Genetics
Sarcoma Diagnosis and Treatment
article

Stemness-associated transcriptional profiles reveal prognostic and microenvironmental heterogeneity in osteosarcoma

Gaohui Fu, Fei Yu, Qiang Lian, Xiaojia Liu, Xiaofei Zheng, Huajun Wang, Yuanchao Zhu, Lei Cui
article en

Abstract

Background Osteosarcoma (OS) is an aggressive primary bone malignancy with poor outcomes in patients with recurrent or metastatic disease. Although molecular profiling has revealed substantial heterogeneity in OS, the relationships between stemness-associated gene expression, patient prognosis, and the tumor immune microenvironment remain incompletely understood. Methods In this study, non-negative matrix factorization of stemness-associated gene expression was used to identify molecular subtypes in TARGET-OS. Functional enrichment, weighted gene co-expression network analysis, somatic mutation profiling, and drug response prediction characterized subtype differences. After joint batch correction of TARGET-OS and GSE21257, an overall survival model based on stemness-associated gene expression was developed using LASSO and Cox regression in TARGET-OS and evaluated in GSE21257. Immune infiltration and single-cell transcriptomic analyses characterized the associated immune features, cellular distribution of the signature, and potential cell–cell interactions. Results Our analysis identified two exploratory stemness-associated OS subtypes with distinct prognoses in the TARGET-OS cohort. C1 showed poorer survival and enrichment of metabolic and DNA repair programs, whereas C2 was enriched for extracellular matrix and immune-related processes. Drug response predictions indicated greater sensitivity to fixed-ratio combinations containing selumetinib in C1 and to cabozantinib in C2. We developed a nine-gene signature that stratified overall survival in both cohorts, with 1-, 3-, and 5-year AUCs of 0.653, 0.751, and 0.711, respectively, in GSE21257. High-risk tumors exhibited lower immune scores and reduced estimated infiltration of CD8 + T Cells and B Cells. Single-cell analysis revealed relatively high signature scores in OS cells and cancer-associated fibroblasts. The high-scoring OS1 subpopulation was enriched for ossification and extracellular matrix-related processes. Communication analysis further predicted COL1A1–CD44 interactions from OS cells and fibroblasts to monocytes. Conclusion Our study characterizes stemness-associated transcriptional heterogeneity in OS and identifies a nine-gene prognostic signature. These findings associate survival differences with metabolic and immune programs and reveal the cellular expression patterns of the signature in tumor and stromal cells.

Frontiers in GeneticsVol. 17
Jinan University (CN), Shenzhen University (CN), Third Affiliated Hospital of Southern Medical University (CN), First Affiliated Hospital of Jinan University (CN), Shenzhen Second People's Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Sanming Project of Medicine in Shenzhen
Good health and well-being
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon